When Three Isn't a Crowd: A Digyny Concept for Treatment-Resistant, Near-Triploid Human Cancers.


Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
19 07 2019
Historique:
received: 30 04 2019
revised: 10 06 2019
accepted: 19 06 2019
entrez: 24 7 2019
pubmed: 25 7 2019
medline: 3 1 2020
Statut: epublish

Résumé

Near-triploid human tumors are frequently resistant to radio/chemotherapy through mechanisms that are unclear. We recently reported a tight association of male tumor triploidy with XXY karyotypes based on a meta-analysis of 15 tumor cohorts extracted from the Mitelman database. Here we provide a conceptual framework of the digyny-like origin of this karyotype based on the germline features of malignant tumors and adaptive capacity of digyny, which supports survival in adverse conditions. Studying how the recombinatorial reproduction via diploidy can be executed in primary cancer samples and HeLa cells after DNA damage, we report the first evidence that diploid and triploid cell sub-populations constitutively coexist and inter-change genomes via endoreduplicated polyploid cells generated through genotoxic challenge. We show that irradiated triploid HeLa cells can enter tripolar mitosis producing three diploid sub-subnuclei by segregation and pairwise fusions of whole genomes. Considering the upregulation of meiotic genes in tumors, we propose that the reconstructed diploid sub-cells can initiate pseudo-meiosis producing two "gametes" (diploid "maternal" and haploid "paternal") followed by digynic-like reconstitution of a triploid stemline that returns to mitotic cycling. This process ensures tumor survival and growth by (1) DNA repair and genetic variation, (2) protection against recessive lethal mutations using the third genome.

Identifiants

pubmed: 31331093
pii: genes10070551
doi: 10.3390/genes10070551
pmc: PMC6678365
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Références

J Cell Comp Physiol. 1960 Nov;56(Suppl 1):1-15
pubmed: 13685203
PLoS One. 2014 Jun 06;9(6):e98712
pubmed: 24905095
Histochem Cell Biol. 2016 Apr;145(4):497-508
pubmed: 26860864
Cancer Res. 1999 Jan 1;59(1):141-50
pubmed: 9892199
Development. 1994 Apr;120(4):947-56
pubmed: 7600970
Theranostics. 2018 Oct 22;8(19):5259-5275
pubmed: 30555545
ScientificWorldJournal. 2017;2017:3578090
pubmed: 28553657
Mol Cytogenet. 2018 May 10;11:31
pubmed: 29760781
J Cell Biol. 2000 Feb 21;148(4):629-34
pubmed: 10684246
Nat Med. 2009 May;15(5):577-83
pubmed: 19396175
Mol Hum Reprod. 2001 Feb;7(2):155-61
pubmed: 11160841
EMBO J. 2010 Apr 7;29(7):1272-84
pubmed: 20186124
Cell Biol Int. 2000;24(9):621-33
pubmed: 10964452
Cell Biol Int. 2000;24(9):635-48
pubmed: 10964453
Oncoscience. 2014 Dec 17;2(1):3-14
pubmed: 25821840
Genes Chromosomes Cancer. 2003 Jun;37(2):207-13
pubmed: 12696070
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1975 Oct 27;84(2):129-33
pubmed: 127440
Exp Cell Res. 2010 Aug 1;316(13):2099-112
pubmed: 20457152
Trends Genet. 2011 Mar;27(3):81-8
pubmed: 21334090
Cell Biol Int. 2008 Sep;32(9):1044-56
pubmed: 18602486
EMBO Rep. 2012 Jun 01;13(6):501-14
pubmed: 22565320
Cancer Res. 2009 Mar 15;69(6):2296-304
pubmed: 19258501
Cell. 2007 Nov 2;131(3):452-62
pubmed: 17981114
Acta Histochem. 2015 Jan;117(1):111-25
pubmed: 25554607
Chromosoma. 1974 Mar 14;45(2):151-62
pubmed: 4135138
Cancer Res. 2001 Jan 15;61(2):538-49
pubmed: 11212247
Proc Natl Acad Sci U S A. 2019 Apr 9;116(15):7353-7362
pubmed: 30910979
Oncotarget. 2018 Dec 28;9(102):37647-37661
pubmed: 30701021
Exp Cell Res. 2009 Sep 10;315(15):2593-603
pubmed: 19463812
Nature. 1948 Jan 17;161(4081):80-3
pubmed: 18898333
Oncogene. 2017 Aug 24;36(34):4887-4900
pubmed: 28436947
Genes (Basel). 2019 Aug 13;10(8):
pubmed: 31412657
Genome Res. 2015 Oct;25(10):1499-507
pubmed: 26430160
Fertil Steril. 2008 Jul;90(1):49-55
pubmed: 17953968
Genes (Basel). 2019 Jan 25;10(2):
pubmed: 30691027
Cell Cycle. 2011 Jun 1;10(11):1873-4
pubmed: 21519193
Cancer. 2011 Sep 1;117(17):4092-9
pubmed: 21365635
Curr Cancer Drug Targets. 2019;19(5):360-367
pubmed: 29968537
Humangenetik. 1967 Nov 29;5(1):65-9
pubmed: 5585061
Chromosoma. 1973 May 14;42(1):71-86
pubmed: 4123256
Humangenetik. 1974 Jan 22;21(1):17-26
pubmed: 4600713
Proc Natl Acad Sci U S A. 2009 May 26;106(21):8671-6
pubmed: 19458043
PLoS One. 2012;7(10):e44609
pubmed: 23115618
Trends Genet. 2011 Nov;27(11):446-53
pubmed: 21872963
Nat Rev Genet. 2005 Nov;6(11):836-46
pubmed: 16304599
Cell Biol Int. 2007 Dec;31(12):1507-10
pubmed: 17936649
In Vitro. 1971 Nov-Dec;7(3):140-5
pubmed: 5163648
Intrinsically Disord Proteins. 2014 Jul 18;2(1):e29997
pubmed: 28232878
Plant Syst Evol. 2017;303(8):1093-1108
pubmed: 29081576
Hum Reprod Update. 1995 May;1(3):201-15
pubmed: 9187939
Radiat Prot Dosimetry. 2002;99(1-4):289-93
pubmed: 12194309
Cell. 2018 May 3;173(4):879-893.e13
pubmed: 29681456
Cancers (Basel). 2018 Apr 15;10(4):
pubmed: 29662021
Development. 1996 Mar;122(3):881-94
pubmed: 8631266
Cell Biol Int. 2005 Dec;29(12):1005-11
pubmed: 16314119
Cell Biol Int. 2011 Jul;35(7):687-95
pubmed: 21250945
Genetica. 1972;43(1):130-47
pubmed: 4624504
BMC Cancer. 2006 Jan 09;6:6
pubmed: 16401344
Genes Dev. 2015 Dec 1;29(23):2405-19
pubmed: 26637526
Nat Genet. 2008 May;40(5):499-507
pubmed: 18443585
Mutat Res. 2013 Aug 30;756(1-2):56-65
pubmed: 23685102
Cancer Biol Ther. 2004 Feb;3(2):207-18
pubmed: 14726689
PLoS One. 2008 Apr 02;3(4):e1871
pubmed: 18392149
Nat Rev Genet. 2010 Nov;11(11):743-4
pubmed: 20877326
Curr Drug Targets. 2016;17(10):1103-10
pubmed: 26343109
Cell Biol Int. 2005 Dec;29(12):1012-8
pubmed: 16310380
Nature. 1994 Jul 21;370(6486):213-6
pubmed: 8028667
Trends Genet. 2015 Jan;31(1):5-10
pubmed: 25445549
Anal Cell Pathol. 1999;18(2):73-85
pubmed: 10468404
Proc Natl Acad Sci U S A. 2010 Nov 23;107(47):20489-93
pubmed: 21059955
Cell Biol Int. 2005 Dec;29(12):1084-97
pubmed: 16316756
Genes Dev. 1997 Oct 15;11(20):2600-21
pubmed: 9334324
Am J Pathol. 1983 Oct;113(1):117-24
pubmed: 6312802
Nature. 2017 Jun 15;546(7658):431-435
pubmed: 28607484
Oncogene. 2014 Jan 2;33(1):116-28
pubmed: 23524583
Chromosoma. 1969;26(3):337-54
pubmed: 5800669
Prenat Diagn. 2003 Jul;23(7):529-34
pubmed: 12868076
Proc Natl Acad Sci U S A. 2005 Apr 12;102(15):5541-6
pubmed: 15809428

Auteurs

Kristine Salmina (K)

Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia.

Bogdan I Gerashchenko (BI)

R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences of Ukraine, 03022 Kyiv, Ukraine.

Michael Hausmann (M)

Kirchhoff Institute for Physics, Heidelberg University, D-69120 Heidelberg, Germany.

Ninel M Vainshelbaum (NM)

Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia.
Institute of Cardiology and Regenerative Medicine, University of Latvia, LV-1004 Riga, Latvia.

Pawel Zayakin (P)

Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia.

Juris Erenpreiss (J)

Riga Stradins University, LV-1007 Riga, Latvia.
Clinic IVF-Riga, LV-1010 Riga, Latvia.

Talivaldis Freivalds (T)

Institute of Cardiology and Regenerative Medicine, University of Latvia, LV-1004 Riga, Latvia.

Mark S Cragg (MS)

Centre for Cancer Immunology, University of Southampton, Southampton SO16 6YD, UK.

Jekaterina Erenpreisa (J)

Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia. katrina@biomed.lu.lv.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH